- Home
- About Us
- Our Products
- Investors
- News
- New Product Pipeline
- Contact Us
Pharmaxis (ASX: PXS, Nasdaq: PXSL) today announced a decision to voluntarily de-list from the Nasdaq Global Market ("Nasdaq").
Pharmaxis has recently completed a review of the demand from existing and potential international investors for the secondary listing of its American Depositary Shares...